Cingulate Inc. Accumulated Other Comprehensive Income
Cingulate Inc. (CING) had Accumulated Other Comprehensive Income of -$3.25 thousand as of 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Balance Sheet › Equity
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-03-10
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.25K.
- 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.78K.
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $165.00.
- 2020-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $165.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2022-06-30 | -$3.25K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$2.78K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $165.00 10-K · filed 2023-03-10 |
| 2020-12-31 | $165.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |